|
[1]
|
Kinoshita, T. and Goto, T. (2019) Molecular Mechanisms of Pulmonary Fibrogenesis and Its Progression to Lung Cancer: A Review. International Journal of Molecular Sciences, 20, Article 1461. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Wu, Q., Zhang, K.J., Jiang, S.M., et al. (2020) p53: A Key Protein That Regulates Pulmonary Fibrosis. Oxidative Medicine and Cellular Longevity, 2020, Article 6635794. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
钟昌会, 冼丽娜, 钱进, 等. 肺纤方通过调控HMGB1/TLR2信号通路抑制特发性肺纤维化的实验研究[J]. 中华中医药学刊, 2023, 41(4): 55-59+263.
|
|
[4]
|
雷凯春. 吡非尼酮治疗特发性肺纤维化的临床疗效及不良反应[D]: [硕士学位论文]. 兰州: 兰州大学, 2018.
|
|
[5]
|
渠景连. 养肺通络法干预Notch信号通路防治肺纤维化的机制研究[D]: [博士学位论文]. 南京: 南京中医药大学, 2015.
|
|
[6]
|
乔虎, 全立欣, 付子佳, 等. 从肺损络伤探讨特发性肺纤维化的发病机制与治疗[J]. 中医药学报, 2023, 51(3): 48-50.
|
|
[7]
|
吴希泽, 康健, 李越, 等. 抵挡汤的研究进展[J/OL]. 中国实验方剂学杂志, 2023: 1-10.
, 2023-07-28.[CrossRef]
|
|
[8]
|
林庶茹, 才丽平. 抵当汤合小陷胸汤化裁方对实验性肺间质纤维化大鼠血清透明质酸与Ⅳ型胶原的影响[J]. 中国中医基础医学杂志, 2005, 11(12): 897-898.
|
|
[9]
|
Hewlett, J.C., Kropski, J.A. and Blackwell, T.S. (2018) Idiopathic Pulmonary Fibrosis: Epitheli-al-Mesenchymal Interactions and Emerging Therapeutic Targets. Matrix Biology, 71-72, 112-127. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
王学. BALF中CCL2、ECM1水平对特发性肺纤维化患者预后的判断价值[D]: [硕士学位论文]. 南京: 南京中医药大学, 2022.
|
|
[11]
|
丛晓东, 曹庆, 何沂, 等. 新型冠状病毒肺炎恢复期肺纤维化的治疗思路与方法[J]. 中医学报, 2020, 35(8): 1583-1586.
|
|
[12]
|
张广成, 吕勇. 中药防治肾小球硬化研究进展[J]. 实用中医药杂志, 2015, 31(1): 73-74.
|
|
[13]
|
Xia, Q.D., Xun, Y., Lu, J.L., et al. (2020) Network Pharmacology and Molecular Docking Analyses on Lianhua Qingwen Capsule Indicate Akt1 is a Potential Target to Treat and Prevent COVID-19. Cell Proliferation, 53, e12949. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
刘雪. EP300在食管鳞癌发生发展中的作用和机制[D]: [硕士学位论文]. 太原: 山西医科大学, 2021.
|
|
[15]
|
Tao, J., Zhang, M., Wen, Z., et al. (2018) Inhibition of EP300 and DDR1 Synergistically Alleviates Pulmonary Fibrosis in Vitro and in Vivo. Biomedicine & Pharmacotherapy, 106, 1727-1733. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Wang, X., Ren, R., Xu, Z., et al. (2021) Tirbanibulin Atte-nuates Pulmonary Fibrosis by Modulating Src/STAT3 Signaling. Frontiers in Pharmacology, 12, Article 693906. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Hao, X., Jin, Y., Zhang, Y., et al. (2023) Inhibition of Oncogenic Src Ameliorates Silica-Induced Pulmonary Fibrosis via PI3K/AKT Pathway. International Journal of Molecular Sciences, 24, Article 774. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Wang, Z., Li, X., Chen, H., et al. (2021) Resveratrol Alleviates Bleomycin-Induced Pulmonary Fibrosis via Suppressing HIF-1α and NF-κB Expression. Aging (Albany NY), 13, 4605-4616. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Montero, P., Milara, J., Roger, I., et al. (2021) Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms. International Journal of Molecular Sciences, 22, Article 6211. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Liu, J., Wang, F. and Luo, F. (2023) The Role of JAK/STAT Pathway in Fibrotic Diseases: Molecular and Cellular Mechanisms. Biomolecules, 13, Article 119. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Mohamad, E.A., Mohamed, Z.N., Hussein, M.A., et al. (2022) GANE can Improve Lung Fibrosis by Reducing Inflammation via Promoting p38MAPK/TGF-β1/NF-κB Signaling Pathway Downregulation. ACS Omega, 7, 3109-3120. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Machahua, C., Montes-Worboys, A., Llatjos, R., et al. (2016) Increased AGE-RAGE Ratio in Idiopathic Pulmonary Fibrosis. Respiratory Research, 17, Article No.144. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Huang, W.J. and Tang, X.X. (2021) Virus Infection Induced Pulmonary Fibrosis. Journal of Translational Medicine, 19, Article No.496. [Google Scholar] [CrossRef] [PubMed]
|